Dr Reddy announces new R&D Chief

Dr Reddys Laboratories Ltd on April 30, 2007 has announced Dr. Rajinder Kumar joining the Company as its President-Research, Development & Commercialization. This appointment follows from the strategic direction of the Company on its journey towards building a strong innovation-led business.

Dr. Kumar will lead and integrate Discovery Research, Global Drug Development and Commercialization efforts, including differentiated products. G V Prasad, Vice Chairman & CEO, of the Company said, "Dr. Kumar joins us at an exciting time. He brings in rich experience and the necessary management bandwidth to consolidate our new Chemical Entity (NCE) Research and drug development efforts. His expertise will help us accelerate our efforts to build a global innovation-led business."

The stock closed the day at Rs.709.60, down by Rs.2.20 or 0.31%. The total traded quantity was 101356 compared to 2 week average of 227810. The stock hit an intraday high of Rs.715 and low of Rs.690.

Source : Equity Bulls

Keywords